Clear Guide Medical signs agreement with USAISR to test effectiveness of Clear Guide ONE

NewsGuard 100/100 Score

Clear Guide Medical has signed a Cooperative Research and Development Agreement with the U.S. Army Institute of Surgical Research to test the physician performance enhancements possible when using the Clear Guide ONE and the VisiTIP needles. Principal Investigator Dr. Jose Salinas, will investigate how the Clear Guide ONE can improve the speed and effectiveness of medical procedures such as vessel cannulation in emergency procedures.

Dorothee Heisenberg, CEO, said: "We are very excited about this partnership with USAISR. ISR is widely acknowledged to be at the forefront of medical technology innovation. Through this partnership we look forward to applying our Computer Assisted Instrument Guidance technology to a number of issues that ISR is addressing."

Insert with confidence. The Clear Guide ONE revolutionizes the practice of interventional medicine with a compact, ergonomic, ultrasound probe attachment. No specialized instrumentation, sensors, or time-consuming calibration steps are required to use the Clear Guide ONE. With the Clear Guide ONE, guidance is "always on" – helping physicians hit their target quickly and easily. The Clear Guide ONE can be attached to most commercially available ultrasound systems, making ultrasound guidance available for most needle- and catheter-based procedures.

Source:

Clear Guide Medical

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New research sheds light on how GLP-1 obesity drugs may change food cravings